波士顿科学临港基地获首证，打破高值医械耗材“临期焦虑”

Core Viewpoint - Boston Scientific has received approval for its OptiCross HD intravascular ultrasound diagnostic catheter, marking a significant achievement for its local production base in China, which aims to enhance the accessibility of high-end medical devices in the Chinese market [3][4]. Group 1: Company Developments - The OptiCross HD catheter is produced at Boston Scientific's new manufacturing facility in Lingang, Shanghai, which has established the first automated production line for intravascular ultrasound catheters in China, with an expected annual output of over 10,000 units [3][4]. - Boston Scientific holds a dominant position in the intravascular ultrasound diagnostic catheter market, accounting for approximately 75% of the total procurement demand in a recent centralized procurement initiative, with a total demand of about 292,400 units [4]. Group 2: Industry Context - The Chinese government has emphasized the high-quality development of medical devices in its recent work report, aligning with Boston Scientific's strategy to localize production and enhance collaboration with advanced Chinese manufacturing [3][5]. - The establishment of local manufacturing capabilities by multinational medical device companies, such as Boston Scientific, reflects the growing scale of the Chinese market and the increasing competitiveness of its manufacturing ecosystem [5][6].